Injectable injection Tauredon is carried deep into the gluteus muscle. Other methods of drug administration are not practiced.
The contents of the ampoule can not be heated.
Standard dosage Tauredon does not exist: the amount of the drug is selected strictly individually.
Given the kinetic data, treatment with Tauredon begins with a trial injection - to assess the tolerability of the drug, for the correct choice of dosage. Next, the doctor determines the maintenance dose of Tauredon, which could provide a stable content of gold in the circulatory system and tissues.
Most often at the first stage, the doctor appoints two Tauredon injections per week, according to this pattern:
- I-III injection involves the administration of 10 mg of medication (Tauredon 10);
- IV-VI injection involves the administration of 20 mg of medication (Taudedon 20);
- with VII injections of 50 mg of medication (tauredon 50) twice weekly, or 100 mg once a week (two doses of tauredon 50).
Such a quantity of the drug should be preserved until a visible effect is obtained, while the total amount of 1600 mg should not be exceeded. If the total amount has already been reached, and clinical relief has not come, then further treatment with Tauredon is considered impractical.
If clinical improvement is evident, further maintenance treatment is prescribed using a monthly amount of the drug 100 mg, or 50 mg once every two weeks. Such therapy can be continued for several months and even years, at the discretion of the doctor.
In pediatrics, Tauredon is administered before the onset of the saturation phase of 0.7-1 mg per kg of child weight per week. With a supportive treatment option, use a dosage of 1 mg per kg of body weight 1-2 times per month.
Introduction Tauredon children are discontinued if the clinical effect of treatment does not occur within 6-9 months.